Pharma Rural Marketing India 2012

Published: 30-May-2012

20 - 22 June 2012
Three-day forum
Meluha The Fern, Mumbai, India

This is the first dedicated platform of its kind that will bring together decision makers from across the marketing and strategic planning functions within the Indian pharmaceutical industry. The high-value networking and business-focused content will identify key challenges within the industry and discover solutions to overcome them

Organiser: CPhI Conferences

Trending Articles

  1. Making Pharmaceuticals 23–24 April 2024 | Exhibition | Coventry, UK
  2. Lounges 23-25 April 2024 | Conference | Messe Karlsruhe, Germany
  3. Interphex 16-18 April 2024 | Conference and Exhibition | New York, US
  4. Vision Pharma <b>28 February - 1 March 2012</b><br> <i>Exhibition</i><br> Messe Karlsruhe, Germany
  5. Advanced Characterisation Techniques for Solid Pharmaceutical Dosage Forms <b>5 July 2013</b><br> <i>PSSRC Open Day</i><br> University of Lille, France

You may also like

Finance

India pharma forecast record growth for 2023

Scoring second only to the USA in ‘growth potential’ and ‘overall competitiveness’ in the CPHI Annual Survey
Finance

Significant growth predicted for CMOs in CPhI Report

By 2025, the report suggests CMOs will account for four of the five top bio manufacturing capacities
Finance

CPhI Awards 2021 open for entries

Held as part of CPhI Worldwide, which takes place 9-11 November 2021, the awards span the entire pharmaceutical supply chain, featuring 15 categories
Media

CPhI survey highlights emerging trends for South Korean pharma

Domestic companies predict a 16% growth in the South Korean pharma market during CPhI Korea
Manufacturing

CPhI releases findings of 2017 India Pharma Market Report

The CPhI report identified a two-tier manufacturing market, forecasted increased acquisitions by Indian companies, predicted a notable improvement in the international reputation of Indian made pharmaceuticals and stated a large majority of domestic companies are calling for urgent Government support to invest in API sites
Finance

Increased confidence of growth in US market, finds CPhI report

But it warns international manufacturers about the need to invest in domestic US sites and indicates that US CDMOs are well placed to take biosimilars development work into commercialisation
Manufacturing

Expanded CPhI Pharma Awards open for entries

New categories introduced for biopharm, ingredients, supply chain and logistics, manufacturing technology and CEO of the year
Subscribe now